Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

17-(allylamino)-17-demethoxygeldanamycin hydroquinone hydrochloride

EU orphan designation number: EU/3/07/512
Active ingredient: 17-(allylamino)-17-demethoxygeldanamycin hydroquinone hydrochloride
Indication: Treatment of malignant gastro intestinal stromal tumours
Sponsor: Voisin Consulting S.A.R.L.
3 rue des Longs Prés, F-92100 Boulogne-Billancourt, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/12/2007 Centralised Orphan - Designation EMEA/OD/076/07 (2007)6026 of 29/11/2007
17/06/2008 Centralised Orphan - Transfer of orphan designation EMEA/OD/076/07/T/01 (2008)2954 of 13/06/2008
08/04/2009 Centralised Orphan - Transfer of orphan designation EMEA/OD/076/07/T/02 (2009)2730 of 03/04/2009
19/01/2011 Centralised Orphan - Removal of orphan designation from Community Register